FLCGX | RBGEX | FLCGX / RBGEX | |
Total Expense Ratio | 1.77 | 1.17 | 151% |
Annual Report Gross Expense Ratio | 1.77 | 1.17 | 151% |
Fund Existence | 40 years | 11 years | - |
Gain YTD | -0.668 | -1.573 | 42% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 35.3M | 20.4B | 0% |
Annual Yield % from dividends | 0.99 | 0.00 | - |
Returns for 1 year | -10.24 | 2.82 | -363% |
Returns for 3 years | 3.86 | 25.26 | 15% |
Returns for 5 years | 37.10 | 40.73 | 91% |
Returns for 10 years | 2.87 | 54.09 | 5% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RGLFX | 24.45 | 0.05 | +0.20% |
American Funds Global Insight R-5 | |||
SSLCX | 49.34 | -0.02 | -0.04% |
DWS Small Cap Core S | |||
MOPAX | 23.01 | -0.10 | -0.43% |
NYLI WMC Small Companies Class A | |||
FSSAX | 23.74 | -0.16 | -0.67% |
Franklin Small Cap Growth Adv | |||
BIPSX | 17.94 | -0.60 | -3.24% |
ProFunds Biotechnology UltraSector Svc |